17 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitors.
The Scripps Research Institute
Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents.
University of Minnesota
An update on therapeutic opportunities offered by cancer glycolytic metabolism.
University of Pisa
Monocarboxylate transporter 1 inhibitors as potential anticancer agents.
Medical School Duluth
Synthesis and structure-activity relationships of pteridine dione and trione monocarboxylate transporter 1 inhibitors.
The Scripps Research Institute
Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes.
Physiologisch-Chemisches Institut Der Eberhard-Karls-Universit£T T£Bingen
Monocarboxylate transporter MCT1 is a target for immunosuppression.
Astrazeneca R&D Charnwood
Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1).
Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology.
Astrazeneca
Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights.
Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management
Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1.
Guang Xi University of Chinese Medicine
Efficient synthesis of novel dialkyl-3-cyanopropylphosphate derivatives and evaluation of their anticholinesterase activity
University of Carthage